IMARC Group, a leading market research company, has recently released a report titled “Regulatory Affairs Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global regulatory affairs outsourcing market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How Big is the Regulatory Affairs Outsourcing Market?

What is Regulatory Affairs Outsourcing?

Regulatory affairs outsourcing is the process of hiring third-party services by the government bodies and private enterprises to ensure public health and safety. The services include managing regulatory requirements for innovator drugs, generic drugs, biologics, biosimilars, etc. The outsourcing organizations control the safety and efficacy of the medicines and ensure that they are safe for consumption. These services are required for clinical trial and patent application, product registration, legal representation, and regulatory writing and publishing. Pharmaceutical companies also opt for these services to seek speedy government approvals.

Request For a Free PDF Sample Report: https://www.imarcgroup.com/regulatory-affairs-outsourcing-market/requestsample

What are the Growth Prospects and Trends in the Regulatory Affairs Outsourcing Industry?

The expanding pharmaceutical and biotechnological industries across the globe are primarily driving the growth of the market. Furthermore, the growing emphasis of numerous pharmaceutical organizations to enhance their operations and supplies, particularly across the developing nations, is also augmenting the market growth. Moreover, outsourcing of regulatory affairs also help in reducing the costs associated with managing in-house resources, such as facilities, technology, training, specialized knowledge and geographic regulations. Additionally, these services are increasingly being used to develop biosimilar and generic drugs, which is further catalyzing the market growth. Besides this, numerous life science-based organizations are rapidly outsourcing non-core functions and regulatory services to increase their overall operational efficiencies, which is expected to further propel the market in the coming years.

Who are the Key Players Operating in the Regulatory Affairs Outsourcing Market?

The competitive landscape of the industry has also been examined along with the profiles of the key players:

• Charles River Laboratories International Inc.
• Covance Inc (Laboratory Corporation of America Holdings)
• Freyr
• ICON Plc
• Medpace Holdings Inc.
• Parexel International Corporation
• Pharmaceutical Product Development LLC
• Promedica International- A California Corporation
• Wuxi AppTec Co. Ltd.

What is Included in Market Segmentation?

The report has categorized the market based on services, company size, category, indication, stage, end user and region.

Breakup by Services:

• Regulatory Consulting
• Legal Representation
• Regulatory Writing and Publishing
• Product Registration and Clinical Trial Applications
• Others

Analysed by Company Size:

• Small
• Medium
• Large 

Breakup by Category:

• Generic Drugs
• Innovator Drugs
• Biologic Drugs
• Biosimilars
• Medical Devices
  • Therapeutic
  • Diagnostic
• Others

Based on Indication:

• Oncology
• Neurology
• Cardiology
• Immunology
• Others

Breakup by Stage:

• Preclinical
• Clinical
• PMA (Post Market Authorization)

Analysis of  End User:

• Medical Device Companies
• Pharmaceutical Companies
• Biotechnology Companies

Regional Insights:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)

Key Highlights of The Report:                                                    

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/